Fennec Pharmaceuticals Announces FDA Acceptance Of New Drug Application Resubmission For PEDMARK
Fennec Pharmaceuticals Inc. (NASDAQ:FENC, TSX:FRX), a specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the resubmission of its New Drug